| Year |
Citation |
Score |
| 2023 |
Ye Q, Wang J, Ducatman B, Raese RA, Rogers JL, Wan YW, Dong C, Padden L, Pugacheva EN, Qian Y, Guo NL. Expression-Based Diagnosis, Treatment Selection, and Drug Development for Breast Cancer. International Journal of Molecular Sciences. 24. PMID 37445737 DOI: 10.3390/ijms241310561 |
0.425 |
|
| 2023 |
Purazo ML, Ice RJ, Shimpi R, Hoenerhoff M, Pugacheva EN. NEDD9 Overexpression Causes Hyperproliferation of Luminal Cells and Cooperates with HER2 Oncogene in Tumor Initiation: A Novel Prognostic Marker in Breast Cancer. Cancers. 15. PMID 36831460 DOI: 10.3390/cancers15041119 |
0.799 |
|
| 2021 |
Whately KM, Voronkova MA, Maskey A, Gandhi J, Loskutov J, Choi H, Yanardag S, Chen D, Wen S, Margaryan NV, Smolkin MB, Purazo ML, Hu G, Pugacheva EN. Nuclear Aurora-A kinase-induced hypoxia signaling drives early dissemination and metastasis in breast cancer: implications for detection of metastatic tumors. Oncogene. PMID 34326467 DOI: 10.1038/s41388-021-01969-1 |
0.523 |
|
| 2021 |
Addison JB, Voronkova MA, Fugett JH, Lin CC, Linville NC, Trinh B, Livengood RH, Smolkin MB, Schaller MD, Ruppert JM, Pugacheva EN, Creighton CJ, Ivanov AV. Functional hierarchy and cooperation of EMT master transcription factors in breast cancer metastasis. Molecular Cancer Research : McR. PMID 33500360 DOI: 10.1158/1541-7786.MCR-20-0532 |
0.486 |
|
| 2020 |
Sizemore G, McLaughlin S, Newman M, Brundage K, Ammer A, Martin K, Pugacheva E, Coad J, Mattes MD, Yu HG. Opening large-conductance potassium channels selectively induced cell death of triple-negative breast cancer. Bmc Cancer. 20: 595. PMID 32586284 DOI: 10.1186/S12885-020-07071-1 |
0.524 |
|
| 2018 |
Wilson HE, Rhodes KK, Rodriguez D, Chahal I, Stanton DA, Bohlen J, Davis M, Infante AM, Hazard-Jenkins H, Klinke DJ, Pugacheva EN, Pistilli EE. Human breast cancer xenograft model implicates peroxisome proliferator-activated receptor signaling as driver of cancer-induced muscle fatigue. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 30559167 DOI: 10.1158/1078-0432.Ccr-18-1565 |
0.416 |
|
| 2018 |
Wright ZC, Loskutov Y, Murphy D, Stoilov P, Pugacheva E, Goldberg AFX, Ramamurthy V. ADP-Ribosylation Factor-Like 2 (ARL2) regulates cilia stability and development of outer segments in rod photoreceptor neurons. Scientific Reports. 8: 16967. PMID 30446707 DOI: 10.1038/S41598-018-35395-3 |
0.313 |
|
| 2018 |
Loskutov YV, Griffin CL, Marinak KM, Bobko A, Margaryan NV, Geldenhuys WJ, Sarkaria JN, Pugacheva EN. LPA signaling is regulated through the primary cilium: a novel target in glioblastoma. Oncogene. PMID 29321663 DOI: 10.1038/S41388-017-0049-3 |
0.465 |
|
| 2018 |
Ma PC, Wu X, Komo S, Lim Z, Yang H, Rhodes K, Jones BC, Lindner DJ, Almeida F, Neumeister V, Velcheti V, Pugacheva E, Martinez I, Yin L, Wen S, et al. PRC-2 epigenetic chromatin reprogramming in ALK-positive (ALK+) lung cancer initial emergence of precision drug resistance. Journal of Clinical Oncology. 36: 12020-12020. DOI: 10.1200/Jco.2018.36.15_Suppl.12020 |
0.324 |
|
| 2018 |
Wu X, Lim Z, Komo S, Walsh C, Yang H, Zhu L, Rhodes K, Jones BC, Pugacheva E, Smolkin M, Seeley EH, Ma PC. Mass spectrometry biomolecular omics profiling and imaging to dissect the initial emergence of molecular drug resistance in ALK-positive (ALK+) lung cancer. Journal of Clinical Oncology. 36: 12018-12018. DOI: 10.1200/Jco.2018.36.15_Suppl.12018 |
0.313 |
|
| 2017 |
Jones BC, Kelley LC, Loskutov YV, Marinak KM, Kozyreva VK, Smolkin MB, Pugacheva EN. Dual Targeting of Mesenchymal and Amoeboid Motility Hinders Metastatic Behavior. Molecular Cancer Research : McR. PMID 28235899 DOI: 10.1158/1541-7786.Mcr-16-0411 |
0.65 |
|
| 2017 |
Marinak K, Kiseleva A, Loskutov Y, Smolkin M, Pugacheva E. Abstract 4863: Aurora-A kinase: a nuclear driver of metastasis Cancer Research. 77: 4863-4863. DOI: 10.1158/1538-7445.Am2017-4863 |
0.328 |
|
| 2017 |
Pugacheva EN, Kozyreva V, Kiseleva A, Ice R, Jones B, Loskutov Y. Abstract 1084: Combination of eribulin and AURKA inhibitor prevents metastatic colonization and eradicates established metastases in breast cancer Cancer Research. 77: 1084-1084. DOI: 10.1158/1538-7445.Am2017-1084 |
0.78 |
|
| 2016 |
Burgett ME, Lathia JD, Roth P, Nowacki AS, Galileo DS, Pugacheva E, Huang P, Vasanji A, Li M, Byzova T, Mikkelsen T, Bao S, Rich JN, Weller M, Gladson CL. Direct contact with perivascular tumor cells enhances integrin αvβ3 signaling and migration of endothelial cells. Oncotarget. PMID 27270311 DOI: 10.18632/Oncotarget.9700 |
0.498 |
|
| 2016 |
Kozyreva VK, Kiseleva A, Ice RJ, Jones BC, Loskutov YV, Matalkah F, Smolkin MB, Marinak K, Livengood RH, Salkeni MA, Wen S, Hazard HW, Layne GP, Walsh CM, Cantrell P, ... ... Pugacheva EN, et al. Combination of Eribulin and Aurora A inhibitor MLN8237 prevents metastatic colonization and induces cytotoxic autophagy in breast cancer. Molecular Cancer Therapeutics. PMID 27235164 DOI: 10.1158/1535-7163.Mct-15-0688 |
0.805 |
|
| 2016 |
Ice R, Kiseleva A, Loskutov Y, Smolkin M, Salkeni A, Hazard H, Layne G, Pugacheva E. Abstract B20: Development of metastatic patient-derived xenografts (PDXs) for accurate assessment of anti-metastatic therapeutics in pre-clinical settings Clinical Cancer Research. 22. DOI: 10.1158/1557-3265.Pdx16-B20 |
0.771 |
|
| 2016 |
Burgett M, Lathia J, Roth P, Nowacki A, Pugacheva E, Huang P, Vasanji A, Meizhang L, Byzova T, Mikkelsen T, Bao S, Rich J, Weller M, Gladson C. Abstract 3380: Direct contact with perivascular tumor cells enhances integrin αvβ3 signaling and migration of endothelial cells Cancer Research. 76: 3380-3380. DOI: 10.1158/1538-7445.Am2016-3380 |
0.42 |
|
| 2015 |
Park J, Schlederer M, Schreiber M, Ice R, Merkel O, Bilban M, Hofbauer S, Kim S, Addison J, Zou J, Ji C, Bunting ST, Wang Z, Shoham M, Huang G, ... ... Pugacheva E, et al. AF1q is a novel TCF7 co-factor which activates CD44 and promotes breast cancer metastasis. Oncotarget. PMID 26079538 DOI: 10.18632/Oncotarget.4136 |
0.794 |
|
| 2015 |
Lin CC, Sharma SB, Farrugia MK, McLaughlin SL, Ice RJ, Loskutov YV, Pugacheva EN, Brundage KM, Chen D, Ruppert JM. Kruppel-like factor 4 signals through microRNA-206 to promote tumor initiation and cell survival. Oncogenesis. 4: e155. PMID 26053033 DOI: 10.1038/oncsis.2015.8 |
0.734 |
|
| 2015 |
Iida J, Dorchak J, Clancy R, Slavik J, Ellsworth R, Katagiri Y, Pugacheva EN, van Kuppevelt TH, Mural RJ, Cutler ML, Shriver CD. Role for chondroitin sulfate glycosaminoglycan in NEDD9-mediated breast cancer cell growth. Experimental Cell Research. 330: 358-70. PMID 25445787 DOI: 10.1016/J.Yexcr.2014.11.002 |
0.45 |
|
| 2015 |
Addison JB, Koontz C, Fugett JH, Creighton CJ, Chen D, Farrugia MK, Padon RR, Voronkova MA, McLaughlin SL, Livengood RH, Lin CC, Ruppert JM, Pugacheva EN, Ivanov AV. KAP1 promotes proliferation and metastatic progression of breast cancer cells. Cancer Research. 75: 344-55. PMID 25421577 DOI: 10.1158/0008-5472.Can-14-1561 |
0.627 |
|
| 2015 |
Kozyulina PY, Loskutov YV, Kozyreva VK, Rajulapati A, Ice RJ, Jones BC, Pugacheva EN. Prometastatic NEDD9 Regulates Individual Cell Migration via Caveolin-1-Dependent Trafficking of Integrins. Molecular Cancer Research : McR. 13: 423-38. PMID 25319010 DOI: 10.1158/1541-7786.Mcr-14-0353 |
0.747 |
|
| 2015 |
Loskutov YV, Kozyulina PY, Kozyreva VK, Ice RJ, Jones BC, Roston TJ, Smolkin MB, Ivanov AV, Wysolmerski RB, Pugacheva EN. NEDD9/Arf6-dependent endocytic trafficking of matrix metalloproteinase 14: a novel mechanism for blocking mesenchymal cell invasion and metastasis of breast cancer. Oncogene. 34: 3662-75. PMID 25241893 DOI: 10.1038/Onc.2014.297 |
0.797 |
|
| 2014 |
Kozyreva VK, McLaughlin SL, Livengood RH, Calkins RA, Kelley LC, Rajulapati A, Ice RJ, Smolkin MB, Weed SA, Pugacheva EN. NEDD9 regulates actin dynamics through cortactin deacetylation in an AURKA/HDAC6-dependent manner. Molecular Cancer Research : McR. 12: 681-93. PMID 24574519 DOI: 10.1158/1541-7786.Mcr-13-0654 |
0.797 |
|
| 2014 |
McLaughlin SL, Ice RJ, Rajulapati A, Kozyulina PY, Livengood RH, Kozyreva VK, Loskutov YV, Culp MV, Weed SA, Ivanov AV, Pugacheva EN. NEDD9 depletion leads to MMP14 inactivation by TIMP2 and prevents invasion and metastasis. Molecular Cancer Research : McR. 12: 69-81. PMID 24202705 DOI: 10.1158/1541-7786.Mcr-13-0300 |
0.811 |
|
| 2014 |
Addison J, Koontz C, McLaughlin S, Livengood R, Pugacheva E, Chen D, Creighton C, Ivanov AV. Abstract LB-2: TRIM28 is overexpressed in breast cancer and regulates the expression of multiple cancer-associated genes Cancer Research. 74. DOI: 10.1158/1538-7445.Am2014-Lb-2 |
0.644 |
|
| 2014 |
Pugacheva EN, McLaughlin S, Ice R, Rajulapati A, Kozyulina P, Livengood R, Kozyreva V, Loskutov Y, Ivanov A, Weed S. Abstract 2013: NEDD9 depletion leads to MMP14 inactivation by TIMP2 and prevents invasion and metastasis Cancer Research. 74: 2013-2013. DOI: 10.1158/1538-7445.Am2014-2013 |
0.803 |
|
| 2013 |
Méndez-Catalá CF, Gretton S, Vostrov A, Pugacheva E, Farrar D, Ito Y, Docquier F, Kita GX, Murrell A, Lobanenkov V, Klenova E. A novel mechanism for CTCF in the epigenetic regulation of Bax in breast cancer cells. Neoplasia (New York, N.Y.). 15: 898-912. PMID 23908591 DOI: 10.1593/neo.121948 |
0.478 |
|
| 2013 |
Ice RJ, McLaughlin SL, Livengood RH, Culp MV, Eddy ER, Ivanov AV, Pugacheva EN. NEDD9 depletion destabilizes Aurora A kinase and heightens the efficacy of Aurora A inhibitors: implications for treatment of metastatic solid tumors. Cancer Research. 73: 3168-80. PMID 23539442 DOI: 10.1158/0008-5472.Can-12-4008 |
0.789 |
|
| 2013 |
Ice RJ, Mahavadi SA, Pugacheva EN. Abstract A094: The influence of pro-metastatic protein NEDD9 expression in supporting distant breast cancer metastasis Molecular Cancer Research. 11. DOI: 10.1158/1557-3125.Advbc-A094 |
0.818 |
|
| 2013 |
Pugacheva EN, Loskutov Y, McLaughlin S, Kozyulina P, Kozyreva V, Ice R, Culp M, Wysolmerski R, Weed S, Ivanov A. Abstract A66: NEDD9 promotes cell invasion through modulation of ARF6 activity and endocytic recycling Cancer Research. 73. DOI: 10.1158/1538-7445.Tim2013-A66 |
0.808 |
|
| 2013 |
Kozyreva VK, Kelley L, McLaughlin SL, Pugacheva EN. Abstract 4934: The role of Aurora A kinase-dependent phosphorylation of cortactin in invadopodia formation. Cancer Research. 73: 4934-4934. DOI: 10.1158/1538-7445.Am2013-4934 |
0.533 |
|
| 2013 |
Loskutov Y, McLaughlin S, Kozyulina P, Kozyreva V, Ice R, Rajulapati A, Culp M, Wysolmerski R, Ivanov A, Weed S, Pugacheva E. Abstract 3782: NEDD9 promotes cell invasion through modulation of Arf6-dependent endocytic recycling. Cancer Research. 73: 3782-3782. DOI: 10.1158/1538-7445.Am2013-3782 |
0.822 |
|
| 2013 |
Ice RJ, McLaughlin S, Culp M, Eddy E, Livengood R, Pugacheva E. Abstract 3384: Depletion of NEDD9 destabilizes Aurora A kinase and augments efficacy of inhibitors. Cancer Research. 73: 3384-3384. DOI: 10.1158/1538-7445.Am2013-3384 |
0.789 |
|
| 2013 |
Addison JB, Galeeva R, Chen D, Pugacheva EN, Ivanov AV. Abstract 3125: KAP1 promotes malignant properties of breast cancer cells and regulates the expression of multiple KRAB-ZNFs. Cancer Research. 73: 3125-3125. DOI: 10.1158/1538-7445.Am2013-3125 |
0.624 |
|
| 2013 |
Jones B, Pugacheva E. Abstract 2640: HEF1 is an important regulator of mesenchymal and amoeboid invasion in breast cancer. Cancer Research. 73: 2640-2640. DOI: 10.1158/1538-7445.Am2013-2640 |
0.612 |
|
| 2012 |
Plotnikova OV, Nikonova AS, Loskutov YV, Kozyulina PY, Pugacheva EN, Golemis EA. Calmodulin activation of Aurora-A kinase (AURKA) is required during ciliary disassembly and in mitosis. Molecular Biology of the Cell. 23: 2658-70. PMID 22621899 DOI: 10.1091/Mbc.E11-12-1056 |
0.376 |
|
| 2012 |
Zhong J, Baquiran JB, Bonakdar N, Lees J, Ching YW, Pugacheva E, Fabry B, O'Neill GM. NEDD9 stabilizes focal adhesions, increases binding to the extra-cellular matrix and differentially effects 2D versus 3D cell migration. Plos One. 7: e35058. PMID 22509381 DOI: 10.1371/Journal.Pone.0035058 |
0.405 |
|
| 2011 |
Plotnikova OV, Pugacheva EN, Golemis EA. Aurora A kinase activity influences calcium signaling in kidney cells. The Journal of Cell Biology. 193: 1021-32. PMID 21670214 DOI: 10.1083/Jcb.201012061 |
0.357 |
|
| 2011 |
Kozyreva VK, McLaughlin SL, Kelley L, Pugacheva EN. Abstract B61: HEF1-dependent Aurora A kinase phosphorylation activates HDAC6 Cancer Research. 71. DOI: 10.1158/1538-7445.Fbcr11-B61 |
0.581 |
|
| 2010 |
Plotnikova OV, Pugacheva EN, Dunbrack RL, Golemis EA. Rapid calcium-dependent activation of Aurora-A kinase. Nature Communications. 1: 64. PMID 20842194 DOI: 10.1038/Ncomms1061 |
0.421 |
|
| 2010 |
Moore FE, Osmundson EC, Koblinski J, Pugacheva E, Golemis EA, Ray D, Kiyokawa H. The WW-HECT protein Smurf2 interacts with the Docking Protein NEDD9/HEF1 for Aurora A activation. Cell Division. 5: 22. PMID 20825672 DOI: 10.1186/1747-1028-5-22 |
0.44 |
|
| 2010 |
Pugacheva EN, McLaughlin S, Hindman B, Golemis EA. Abstract 1086: The role of HEF1 protein in stabilization and activation of AurA kinase in metastatic breast cancer Cancer Research. 70: 1086-1086. DOI: 10.1158/1538-7445.Am10-1086 |
0.661 |
|
| 2009 |
Plotnikova OV, Pugacheva EN, Golemis EA. Primary cilia and the cell cycle. Methods in Cell Biology. 94: 137-60. PMID 20362089 DOI: 10.1016/S0091-679X(08)94007-3 |
0.384 |
|
| 2009 |
Izumchenko E, Singh MK, Plotnikova OV, Tikhmyanova N, Little JL, Serebriiskii IG, Seo S, Kurokawa M, Egleston BL, Klein-Szanto A, Pugacheva EN, Hardy RR, Wolfson M, Connolly DC, Golemis EA. NEDD9 promotes oncogenic signaling in mammary tumor development. Cancer Research. 69: 7198-206. PMID 19738060 DOI: 10.1158/0008-5472.Can-09-0795 |
0.552 |
|
| 2008 |
Plotnikova OV, Golemis EA, Pugacheva EN. Cell cycle-dependent ciliogenesis and cancer. Cancer Research. 68: 2058-61. PMID 18381407 DOI: 10.1158/0008-5472.Can-07-5838 |
0.472 |
|
| 2008 |
Méndez-Catalá C, Cherhukhin I, Docquier F, Farrar D, Pugacheva E, Vostrov A, Klenova E. Investigation into the molecular mechanism of the antiapoptotic functions of CTCF in breast cancer cells using a proteomics approach Breast Cancer Research. 10. DOI: 10.1186/bcr1903 |
0.421 |
|
| 2007 |
Pugacheva EN, Jablonski SA, Hartman TR, Henske EP, Golemis EA. HEF1-dependent Aurora A activation induces disassembly of the primary cilium. Cell. 129: 1351-63. PMID 17604723 DOI: 10.1016/J.Cell.2007.04.035 |
0.374 |
|
| 2007 |
Natarajan M, Stewart JE, Golemis EA, Pugacheva EN, Alexandropoulos K, Cox BD, Wang W, Grammer JR, Gladson CL. Erratum: HEF1 is a necessary and specific downstream effector of FAK that promotes the migration of glioblastoma cells Oncogene. 26: 7282-7282. DOI: 10.1038/Sj.Onc.1210837 |
0.431 |
|
| 2006 |
Pugacheva EN, Roegiers F, Golemis EA. Interdependence of cell attachment and cell cycle signaling. Current Opinion in Cell Biology. 18: 507-15. PMID 16919436 DOI: 10.1016/J.Ceb.2006.08.014 |
0.397 |
|
| 2006 |
Pugacheva EN, Golemis EA. HEF1-aurora A interactions: points of dialog between the cell cycle and cell attachment signaling networks. Cell Cycle (Georgetown, Tex.). 5: 384-91. PMID 16479169 DOI: 10.4161/Cc.5.4.2439 |
0.422 |
|
| 2006 |
Dadke D, Jarnik M, Pugacheva EN, Singh MK, Golemis EA. Deregulation of HEF1 impairs M-phase progression by disrupting the RhoA activation cycle. Molecular Biology of the Cell. 17: 1204-17. PMID 16394104 DOI: 10.1091/Mbc.E05-03-0237 |
0.366 |
|
| 2006 |
Natarajan M, Stewart JE, Golemis EA, Pugacheva EN, Alexandropoulos K, Cox BD, Wang W, Grammer JR, Gladson CL. HEF1 is a necessary and specific downstream effector of FAK that promotes the migration of glioblastoma cells. Oncogene. 25: 1721-32. PMID 16288224 DOI: 10.1038/Sj.Onc.1209199 |
0.497 |
|
| 2005 |
Pugacheva EN, Golemis EA. The focal adhesion scaffolding protein HEF1 regulates activation of the Aurora-A and Nek2 kinases at the centrosome. Nature Cell Biology. 7: 937-46. PMID 16184168 DOI: 10.1038/Ncb1309 |
0.409 |
|
| 2005 |
Vatolin S, Abdullaev Z, Pack SD, Flanagan PT, Custer M, Loukinov DI, Pugacheva E, Hong JA, Morse H, Schrump DS, Risinger JI, Barrett JC, Lobanenkov VV. Conditional expression of the CTCF-paralogous transcriptional factor BORIS in normal cells results in demethylation and derepression of MAGE-A1 and reactivation of other cancer-testis genes. Cancer Research. 65: 7751-62. PMID 16140943 DOI: 10.1158/0008-5472.CAN-05-0858 |
0.355 |
|
| 2002 |
Golemis EA, Ochs MF, Pugacheva EN. Signal transduction driving technology driving signal transduction: factors in the design of targeted therapies. Journal of Cellular Biochemistry. Supplement. 42-52. PMID 11842427 DOI: 10.1002/Jcb.10064 |
0.307 |
|
| Show low-probability matches. |